Bridger Management’s DermTech, Inc. Common Stock DMTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-208,600
Closed -$826K 43
2022
Q3
$826K Sell
208,600
-142,200
-41% -$874K 0.25% 40
2022
Q2
$1.94M Sell
350,800
-18,400
-5% -$151K 0.44% 35
2022
Q1
$5.42M Buy
369,200
+143,100
+63% +$1.92M 0.89% 28
2021
Q4
$3.57M Buy
+226,100
New +$5.43M 0.46% 36
2021
Q2
Sell
-122,877
Closed -$6.24M 48
2021
Q1
$6.24M Sell
122,877
-57,427
-32% -$3M 0.58% 39
2020
Q4
$5.85M Buy
+180,304
New +$2.56M 0.45% 37

Other funds holding DMTK

Bridger Management's DMTK Position: Q4 2022 in Review

Bridger Management sold out of DermTech, Inc. Common Stock (DMTK) in Q4 2022, closing a stake of 208,600 shares — an estimated $826K sold.

Bridger Management first reported a position in DMTK in Q4 2020 and held it in 6 quarters. The position peaked at $6.24M in Q1 2021. 94 funds tracked by Wall St. Rank hold DMTK as of Q4 2022.

  • Bridger Management reported no remaining DermTech, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Bridger Management sold 208,600 DermTech, Inc. Common Stock shares in Q4 2022, an estimated $826K.
  • Bridger Management first reported a position in DermTech, Inc. Common Stock in Q4 2020 and held it in 6 quarters.
  • Bridger Management's DermTech, Inc. Common Stock position peaked at $6.24M in Q1 2021.
  • 94 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q4 2022.

Based on Bridger Management's 13F filing for Q4 2022, filed 15 Feb 2023.